BARCLAYS PLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,869
-56.6%
330,906
-50.1%
0.00%
-66.7%
Q2 2023$8,907
+177.1%
662,685
+241.9%
0.01%
+500.0%
Q1 2023$3,214
-40.7%
193,839
-33.5%
0.00%
-50.0%
Q4 2022$5,421
-99.8%
291,453
+6.2%
0.00%
-50.0%
Q3 2022$3,519,000
+10250.0%
274,314
+5605.4%
0.00%
Q2 2022$34,000
-74.8%
4,808
-70.3%
0.00%
Q1 2022$135,000
-91.5%
16,215
-93.1%
0.00%
Q4 2021$1,594,000
+378.7%
235,720
+276.4%
0.00%
Q3 2021$333,000
-61.1%
62,622
-57.9%
0.00%
Q2 2021$857,000
-14.5%
148,838
-31.6%
0.00%
-100.0%
Q1 2021$1,002,000
+18.0%
217,541
-14.5%
0.00%
Q4 2020$849,000
+7.3%
254,488
-4.7%
0.00%
Q3 2020$791,000
-38.5%
266,899
-4.1%
0.00%
-100.0%
Q2 2020$1,286,000
+31.1%
278,355
+9.3%
0.00%0.0%
Q1 2020$981,000
+131.4%
254,683
+125.3%
0.00%
Q4 2019$424,000
+61.2%
113,060
+128.6%
0.00%
Q3 2019$263,000
+10.0%
49,450
-20.5%
0.00%
Q2 2019$239,000
+71.9%
62,193
+128.1%
0.00%
Q1 2019$139,000
+6850.0%
27,261
+2304.0%
0.00%
Q4 2018$2,000
-98.5%
1,134
-96.9%
0.00%
Q3 2018$137,000
+522.7%
36,159
+411.7%
0.00%
Q2 2018$22,000
-71.1%
7,066
-77.9%
0.00%
Q1 2018$76,000
+46.2%
32,031
+137.8%
0.00%
Q4 2017$52,000
-55.2%
13,469
-70.8%
0.00%
Q3 2017$116,000
+163.6%
46,080
+186.6%
0.00%
Q2 2017$44,000
+633.3%
16,079
+101.3%
0.00%
Q2 2016$6,000
-64.7%
7,986
-3.7%
0.00%
Q4 2015$17,000
+1600.0%
8,291
+2004.3%
0.00%
Q3 2015$1,000
-83.3%
394
-72.7%
0.00%
Q2 2015$6,0001,4410.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders